June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Ingo Hartung: Kevan Shokat Opens AACR25 with KRas Breakthroughs in Targeted Therapy
Apr 29, 2025, 04:30

Ingo Hartung: Kevan Shokat Opens AACR25 with KRas Breakthroughs in Targeted Therapy

Ingo Hartung, Executive Director, Head of Medicinal Chemistry and Drug Design at Merck Healthcare, shared a post on X:

“Highly significant selection of the first speaker in the opening plenary at AACR25: Kevan Shokat talking about the impressive progress in targeting KRas with small molecules. Decades of investing into fundamental science now generating first clinical impact. And much more to come.”

Paolo Tarantino, Clinical Research Fellow at Dana-Farber Cancer Institute, shared a post by Ingo Hartungadding:
“KRAS: from undruggable to this.”
Ingo Hartung: Kevan Shokat Opens AACR25 with KRas Breakthroughs in Targeted Therapy